WCI sponsors 5th Annual Jean Sindab Triple Negative Breast Cancer Symposium

The 5th Annual Jean Sindab Triple Negative Breast Cancer Symposium, sponsored by the Winship Cancer Institute at Emory University, provides an intimate learning environment in which the most current advances in triple-negative breast cancers (TNBC) will be explored. Nationally recognized speakers will review research, clinical experiences, and provide updates on current research in TNBC. TNBC affects young women and African American women disproportionately. TNBC has no targeted therapies and chemotherapy is effective only in a minority of cases. This symposium increases awareness of TNBC and focuses on current, ongoing research to improve outcomes for patients with this disease.

This live activity is designed for medical oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists, and other healthcare providers involved with or interested in the diagnosis, treatment, and management of breast cancer.

At the conclusion of the conference, the attendees should be able to:

• Update adjuvant and neo-adjuvant approaches for treating patients with TNBC

• Discuss different pathologic subtypes of TNBC

• Update novel therapeutic approaches for metastatic TNBC

• Discuss local therapeutic approaches for TNBC
• Discuss molecular subtyping of TNBC

• Discuss IGF1R signaling in TNBC

• Discuss the role of DNA repair defects in TNBC

• Discuss issues, including fatigue, in breast cancer survivors

Core Competencies: Patient Care and Medical Knowledge

Continuing Medical Education:

The Emory University School of Medicine designates this live activity for a maximum of 7 AMA Physicians Recognition Award Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.